Skip to content

Ghrelin Resistance in Adolescents With Idiopathic Scoliosis

Ghrelin Cellular Resistance Study in Adolescents With Idiopathic Scoliosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02829476
Enrollment
45
Registered
2016-07-12
Start date
2010-03-31
Completion date
2012-07-31
Last updated
2017-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis

Keywords

Adolescent idiopathic Scoliosis, Ghrelin

Brief summary

Adolescent idiopathic Scoliosis (AIS) is the most common spine pathology. It is opposed to secondary scoliosis due to chronic diseases. Many hypotheses have been made to elucidate the origin of this illness. Recently, the melatonin pathway has been investigated as pinealectomy of the chicken creates a scoliosis that resembles AIS and melatonin supplementation reverses the process. In addition administration of melatonin to AIS patients improved the pathology. However this hypothesis has shown controversial results. Recent studies have demonstrated melatonin cellular resistance in osteoblastic cells from AIS patients. Melatonin acts through G protein coupled receptor (GPCR), mainly using the Gi pathway. In AIS osteoblasts, this pathway is blocked leading to a decrease in the inactivation of the adenylyl cyclase and therefore maintenance of high level of cyclic adenosine monophosphate (cAMP) concentrations in the cells. As modulation of cAMP is important for osteogenesis such resistance may be critical for the initiation or the development of AIS. Gi signalization is used by several other GPCR, thus, this hormonal resistance could logically be found in other hormonal or mediator pathways. A precedent study previously focused on ghrelin in AIS, and demonstrated that AIS patients possess elevated plasmatic values of ghrelin. This study also observed decreased response to ghrelin in AIS cultures osteoblasts.

Interventions

BIOLOGICALOsteoblast sample

culture osteoblasts obtained from vertebrae fragments from 30 patients with AIS and from 10 control patients with secondary scoliosis

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

Group 1 : * AIS : spine deformity with angle above 10°,without detected cause * Informed consent obtained Group 2 : * Secondary scoliosis due to chronic illness, neurologic or syndromic, eligible for spine surgery * Spine surgery for reason other than scoliosis * Informed consent obtained

Exclusion criteria

* Not primary scoliosis * No consent * Legal obstacle

Design outcomes

Primary

MeasureTime frameDescription
Testing ghrelin cellular resistance by intracellular cAMP dosagebaselineTesting ghrelin cellular resistance in AIS by measuring the variation of the intracellular cAMP level in response to ghrelin in osteoblast cells in vitro of AIS patients versus controls

Secondary

MeasureTime frameDescription
ghrelin level in serumbaselineMeasure the ghrelin level in the serum of AIS patients versus controls
ghrelin levels in cellular supernatantsbaselineMeasure the ghrelin levels in cellular supernatants of osteoblasts from AIS and controls patients in order to evaluate the ghrelin production of the cells.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026